Literature DB >> 18158235

The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients.

Sonja Praprotnik1, Snezna Sodin-Semrl, Matija Tomsic, Yehuda Shoenfeld.   

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease, which can arise from a combination of genetic and environmental factors. In the past, infections (Epstein Barr virus, parvovirus B-19) have been indicated to play a causative role in the development of autoimmune diseases, such as SLE. On the other hand, with the emergence of the "hygiene hypothesis" infections have also shown to play a protective role in autoimmune diseases. Two case studies are presented which provide clinical evidence of SLE patients with severe, long-term disease, despite immunosuppresive therapy. The course of both diseases changed remarkably after they experienced infections with multiple microbes (bacterial, viral and fungal). Surprisingly, their clinical and laboratory signs of SLE normalized and they are now symptom-free after 5 and 3year follow-ups. The second patient has even had a normal pregnancy, which was a trigger factor for disease flare in the past. The infections presumably changed the host immune systems and the mechanisms of their protective effects are most likely multifactorial. Our cases illustrate that infections could be beneficial in SLE patients and re-directing research toward novel innate-based SLE therapy should be explored.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18158235     DOI: 10.1016/j.jaut.2007.11.002

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  14 in total

1.  Pregnancy and catastrophic antiphospholipid syndrome.

Authors:  Jose A Gómez-Puerta; Jose Sanin-Blair; Claudio Galarza-Maldonado
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

2.  Infection in systemic lupus erythematosus: friend or foe?

Authors:  Lisa Francis; Andras Perl
Journal:  Int J Clin Rheumtol       Date:  2010-02-01

Review 3.  Infections and systemic lupus erythematosus.

Authors:  S Esposito; S Bosis; M Semino; D Rigante
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-09       Impact factor: 3.267

Review 4.  Do you have a probiotic in your future?

Authors:  Maria G Dominguez-Bello; Martin J Blaser
Journal:  Microbes Infect       Date:  2008-08-13       Impact factor: 2.700

Review 5.  The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology.

Authors:  Eric M Jacobson; Amanda Huber; Yaron Tomer
Journal:  J Autoimmun       Date:  2008-01-04       Impact factor: 7.094

6.  In vitro induction of regulatory T cells by anti-CD3 antibody in humans.

Authors:  Michal Abraham; Arnon Karni; Adi Dembinsky; Ariel Miller; Roopali Gandhi; David Anderson; Howard L Weiner
Journal:  J Autoimmun       Date:  2008 Feb-Mar       Impact factor: 7.094

Review 7.  Cell damage and autoimmunity: a critical appraisal.

Authors:  Ian R Mackay; Natasha V Leskovsek; Noel R Rose
Journal:  J Autoimmun       Date:  2008 Feb-Mar       Impact factor: 7.094

Review 8.  Probiotics and immunity.

Authors:  Andrea T Borchers; Carlo Selmi; Frederick J Meyers; Carl L Keen; M Eric Gershwin
Journal:  J Gastroenterol       Date:  2009-01-22       Impact factor: 7.527

9.  Adjuvants- and vaccines-induced autoimmunity: animal models.

Authors:  Jiram Torres Ruiz; Luis Luján; Miri Blank; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 4.505

Review 10.  Infections and Systemic Lupus Erythematosus: Binding or Sparring Partners?

Authors:  Donato Rigante; Susanna Esposito
Journal:  Int J Mol Sci       Date:  2015-07-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.